About this trial
This study aims to test the efficacy of a parent-only approach to treating anxiety disorders in adolescents: SPACE (Supportive Parenting for Anxious Childhood Emotions). The comparator is another parent-based approach, PES (Parent Education and Support). The study design is a randomized controlled trial with 2 treatment arms and 3 assessment points (pre, post, and follow-up) using questionnaire data and clinical interviews.
Eligibility criteria
Qualifiers
Meet criteria for a primary DSM-5 AD, including separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, specific phobia, panic disorder, and agoraphobia (determined by the ADIS-C/P).
Cease all other psychosocial treatment, upon consultation with the project staff and service provider.
Not currently use any psychotropic medication, other than a stable dose (i.e., same dose for a minimum of 6 months prior to enrollment; no changes during course of the study) of a stimulant medication or selective serotonin reuptake inhibitor (SSRI).
Have an eligible and willing participating parent (see parent exclusions below).
Disqualifiers
Meet criteria for any DSM-5 disorder more impairing than the most impairing AD (determined by the ADIS-C/P).
Have any of the following disorders: autism spectrum disorder; intellectual disability; neurocognitive disorders; bipolar disorder; schizophrenia and other psychotic disorders; and alcohol and substance use disorders (determined by the Health History Form and ADIS-C/P).
Report a suicide attempt in the last 3 months, or current suicide intent and plans (determined by the ASQ).
Be a victim of past or present undisclosed abuse requiring investigation or ongoing supervision by the Department of Social Services.
Trial design
Treatments tested in this trial
- Supportive Parenting for Anxious Childhood Emotions (SPACE)
- Parent Educational Support (PES)
Treatment groups
Sponsors and collaborators
Yale University
Lead sponsor
MQ: Transforming Mental Health
Collaborator